Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Georgios, Tsirikos"'
Autor:
Theodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, Serafeim Chrysikos, Eirini Vasarmidi, Pierre-Antoine Juge, Styliani Vizirianaki, Eleni Bibaki, Argyro Reppa, Prodromos Sidiropoulos, Matthaios Katsaras, Vasilina Sotiropoulou, Panagiota Tsiri, Electra Koulousousa, Eva Theochari, Georgios Tsirikos, Ioannis Christopoulos, Elli Malakounidou, Eirini Zarkadi, Fotios Sampsonas, Georgios Hillas, Theofanis Karageorgas, Dimitrios Daoussis, Christina Kalogeropoulou, Katerina Dimakou, Nikolaos Tzanakis, Raphael Borie, Philippe Dieudé, Katerina Antoniou, Bruno Crestani, Demosthenes Bouros, Argyris Tzouvelekis
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
IntroductionMyositis associated interstitial lung disease (ILD) seems to be an under-recognized entity.MethodsIn this multicenter, retrospective study, we recorded between 9/12/2019 and 30/9/2021 consecutive patients who presented in five different I
Externí odkaz:
https://doaj.org/article/e4f986e3455643bc85e6e8b48da6c7a3
Autor:
Theodoros Karampitsakos, Elli Malakounidou, Ourania Papaioannou, Vasilina Dimakopoulou, Eirini Zarkadi, Matthaios Katsaras, Panagiota Tsiri, Georgios Tsirikos, Vasiliki Georgiopoulou, Ioanna Oikonomou, Christos Davoulos, Dimitrios Velissaris, Fotios Sampsonas, Markos Marangos, Karolina Akinosoglou, Argyris Tzouvelekis
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Data on the safety and efficacy profile of tocilizumab in patients with severe COVID-19 needs to be enriched. Methods In this open label, prospective study, we evaluated clinical outcomes in consecutive patients with COVID-19 and
Externí odkaz:
https://doaj.org/article/fc98827ed10045ffafba75de488521b4
Autor:
Theodoros, Karampitsakos, Ourania, Papaioannou, Panagiota, Tsiri, Matthaios, Katsaras, Andreas, Katsimpris, Andreas P, Kalogeropoulos, Elli, Malakounidou, Eirini, Zarkadi, Georgios, Tsirikos, Vasiliki, Georgiopoulou, Vasilina, Sotiropoulou, Electra, Koulousousa, Charikleia, Chourpiliadi, Apostolos, Matsioulas, Maria, Lagadinou, Fotios, Sampsonas, Karolina, Akinosoglou, Markos, Marangos, Argyris, Tzouvelekis
Publikováno v:
Clinical Microbiology and Infection. 29:372-378
BackgroundTocilizumab and baricitinib have proven efficacy in COVID-19. There were no randomized-controlled trials comparing these compounds in patients with COVID-19.Materials/Patients and MethodsIn this open label, randomized controlled trial, we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1d61f2aaa391781128b14540d89bfe
https://doi.org/10.1016/j.cmi.2022.10.015
https://doi.org/10.1016/j.cmi.2022.10.015
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vasilina Dimakopoulou, Karolina Akinosoglou, Argyris Tzouvelekis, Dimitrios Velissaris, Fotios Sampsonas, Elli Malakounidou, Georgios Tsirikos, Panagiota Tsiri, Christos Davoulos, Markos Marangos, Theodoros Karampitsakos, Ourania Papaioannou, Eirini Zarkadi, Ioanna Oikonomou, Vasiliki Georgiopoulou, Matthaios Katsaras
Background: Data on the safety and efficacy profile of tocilizumab in patients with severe COVID-19 needs to be enriched.Methods: In this open label, prospective study, we evaluated clinical outcomes in consecutive patients with COVID-19 and PaO2/FiO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a58fd8ebaf73bfa564242d71f210d00
https://doi.org/10.21203/rs.3.rs-824171/v1
https://doi.org/10.21203/rs.3.rs-824171/v1
Autor:
Serafeim Chrysikos, Theofanis Karageorgas, Argyris Tzouvelekis, Elli Malakounidou, Vasilios Tzilas, Panagiota Tsiri, Matthaios Katsaras, Katerina Dimakou, Eirini Zarkadi, Evangelos Bouros, Demosthenes Bouros, Aggeliki Bellou, Panagiotis Efthymiou, Fotios Sampsonas, Nikolaos Ntoulias, Georgios Tsirikos, Theodoros Karampitsakos, Vasilina Sotiropoulou, Ourania Papaioannou
Publikováno v:
ILD / DPLD of known origin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0197ade7df61886789940414b379b3c6
https://doi.org/10.1183/13993003.congress-2021.pa2246
https://doi.org/10.1183/13993003.congress-2021.pa2246
Autor:
Ourania Papaioannou, Elli Malakounidou, Georgios Tsirikos, Panagiota Tsiri, Ioanna Oikonomou, Markos Marangos, Eirini Zarkadi, Theodoros Karampitsakos, Fotios Sampsonas, Karolina Akinosoglou, Vassilina Dimakopoulou, Argyris Tzouvelekis, Matthaios Katsaras, Christos Davoulos, Vasiliki Georgiopoulou
Publikováno v:
Respiratory infections and bronchiectasis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::349e32e53d066d15f9c00971396cc313
https://doi.org/10.1183/13993003.congress-2021.oa1665
https://doi.org/10.1183/13993003.congress-2021.oa1665
Autor:
Vasilios Tzilas, Fotios Sampsonas, Georgios Tsirikos, Demosthenes Bouros, Serafeim Chrysikos, Evangelos Bouros, Christina Kalogeropoulou, Elli Malakounidou, Panagiota Tsiri, Matthaios Katsaras, Eirini Zarkadi, Evangelia Koukaki, Nikolaos Ntoulias, Alexandra Kazantzi, Argyrios Tzouvelekis, Vasilina Sotiropoulou, Theodoros Karampitsakos, Panagiotis Efthymiou, Ourania Papaioannou
Publikováno v:
Respiration; international review of thoracic diseases. 101(3)
Introduction: Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is amenable to avoid potential side effects. Methods: Functional indice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c7cd8bdeff188f214a859bf72a6d60
https://pubmed.ncbi.nlm.nih.gov/34592744
https://pubmed.ncbi.nlm.nih.gov/34592744